Arp5 is also identified as a T-cell acute lymphocytic leukemia and sarcoma antigen (Lee et al., 2003), although its contribution to carcinogenesis and sarcomagenesis is unclear. Here, ACTR5 is linked to T-cell acute lymphoblastic leukemia.